Chronic diarrhea, defined as loose stools persisting for over four weeks, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing this common but complex condition in clinical practice.
Diagnosis should begin with a detailed medical history, including onset, duration, frequency, and characteristics of the diarrhea, as well as associated symptoms. A thorough physical examination should follow, focusing on signs of dehydration, malnutrition, or systemic disease. Laboratory tests, including complete blood count, stool studies, and thyroid function tests, can provide further insights. When necessary, endoscopic examinations and imaging studies may be employed.
Common causes of chronic diarrhea include irritable bowel syndrome, inflammatory bowel disease, malabsorption syndromes, and chronic infections. Less common causes include endocrine disorders, such as hyperthyroidism, and malignancies. Identifying the cause can often be challenging due to overlapping symptoms and the need for specialized tests.
Treatment should be tailored to the underlying cause. Symptomatic relief can be achieved with antidiarrheal agents, dietary modifications, and probiotics. For inflammatory causes, immunosuppressive agents may be required. In cases of malabsorption, nutritional supplementation and dietary modifications are key. Antibiotics may be necessary for chronic infections. Early referral to a gastroenterologist should be considered for complex cases.
Chronic diarrhea is a complex condition requiring a comprehensive diagnostic approach and tailored treatment strategies. A thorough history and physical examination, along with appropriate laboratory and imaging studies, are crucial for accurate diagnosis. Treatment should be etiology-specific and may require a multidisciplinary approach. Through a better understanding of this condition, clinicians can improve patient outcomes and quality of life.
1.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
2.
Prostate cancer detection with PET CT and PET MRI is comparable.
3.
Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans
4.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
5.
EHA: European Hematology Association
1.
Tumor Microenvironment Mapping in Cancer Care
2.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
3.
Preventing Treatment-Induced Peripheral Neuropathy in Cancer Care
4.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
5.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Understanding Blood Clotting Disorders
2.
Thromboprophylaxis In Medical Settings
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation